A. P. Johnson

583 total citations
10 papers, 344 citations indexed

About

A. P. Johnson is a scholar working on Epidemiology, Infectious Diseases and Clinical Biochemistry. According to data from OpenAlex, A. P. Johnson has authored 10 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 4 papers in Infectious Diseases and 3 papers in Clinical Biochemistry. Recurrent topics in A. P. Johnson's work include Bacterial Identification and Susceptibility Testing (3 papers), Antibiotic Resistance in Bacteria (3 papers) and Antimicrobial Resistance in Staphylococcus (3 papers). A. P. Johnson is often cited by papers focused on Bacterial Identification and Susceptibility Testing (3 papers), Antibiotic Resistance in Bacteria (3 papers) and Antimicrobial Resistance in Staphylococcus (3 papers). A. P. Johnson collaborates with scholars based in United Kingdom, Nepal and Ireland. A. P. Johnson's co-authors include Theresa Lamagni, B. Cookson, David M. Livermore, Jennie Wilson, Suzanne Elgohari, Elizabeth Sheridan, Ruth Blackburn, D. M. Livermore, Mark H. Wilcox and Rosy Reynolds and has published in prestigious journals such as Journal of Antimicrobial Chemotherapy, Clinical Microbiology and Infection and Archives of Disease in Childhood.

In The Last Decade

A. P. Johnson

10 papers receiving 330 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. P. Johnson United Kingdom 8 139 127 127 115 114 10 344
F. C. Tenover United States 6 128 0.9× 115 0.9× 147 1.2× 111 1.0× 120 1.1× 8 368
Cássia Maria Zoccoli Brazil 8 116 0.8× 69 0.5× 107 0.8× 76 0.7× 135 1.2× 13 332
Fawzia Alotaibi Saudi Arabia 11 103 0.7× 120 0.9× 81 0.6× 83 0.7× 146 1.3× 18 339
P Behar Brazil 6 95 0.7× 92 0.7× 96 0.8× 83 0.7× 86 0.8× 9 285
Marta Antunes de Souza Brazil 5 119 0.9× 92 0.7× 98 0.8× 68 0.6× 92 0.8× 6 302
Ines Noll Germany 10 125 0.9× 104 0.8× 92 0.7× 87 0.8× 117 1.0× 24 333
E. Tacconelli Italy 8 147 1.1× 123 1.0× 76 0.6× 60 0.5× 78 0.7× 14 381
Nestor Mojica United States 5 127 0.9× 52 0.4× 104 0.8× 95 0.8× 94 0.8× 7 300
J. K. Oberoi India 8 85 0.6× 169 1.3× 78 0.6× 56 0.5× 91 0.8× 11 304
Toshiki Kajihara Japan 13 139 1.0× 127 1.0× 89 0.7× 102 0.9× 127 1.1× 34 454

Countries citing papers authored by A. P. Johnson

Since Specialization
Citations

This map shows the geographic impact of A. P. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. P. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. P. Johnson more than expected).

Fields of papers citing papers by A. P. Johnson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. P. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. P. Johnson. The network helps show where A. P. Johnson may publish in the future.

Co-authorship network of co-authors of A. P. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of A. P. Johnson. A scholar is included among the top collaborators of A. P. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. P. Johnson. A. P. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Livermore, D. M., Russell Hope, Rosy Reynolds, et al.. (2013). Declining cephalosporin and fluoroquinolone non-susceptibility among bloodstream Enterobacteriaceae from the UK: links to prescribing change?. Journal of Antimicrobial Chemotherapy. 68(11). 2667–2674. 78 indexed citations
2.
Johnson, A. P. & Mark H. Wilcox. (2012). Fidaxomicin: a new option for the treatment of Clostridium difficile infection. Journal of Antimicrobial Chemotherapy. 67(12). 2788–2792. 25 indexed citations
3.
Johnson, A. P.. (2011). Kucers' The Use of Antibiotics, Sixth Edition. Journal of Antimicrobial Chemotherapy. 67(2). 517–517. 7 indexed citations
4.
Wilson, Jennie, Suzanne Elgohari, David M. Livermore, et al.. (2010). Trends among pathogens reported as causing bacteraemia in England, 2004–2008. Clinical Microbiology and Infection. 17(3). 451–458. 137 indexed citations
5.
Johnson, A. P., Mike Sharland, C. M. Goodall, et al.. (2010). Enhanced surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in children in the UK and Ireland. Archives of Disease in Childhood. 95(10). 781–785. 25 indexed citations
6.
Johnson, A. P.. (2000). Susceptibility to quinupristin/dalfopristin and other antibiotics of vancomycin-resistant enterococci from the UK, 1997 to mid-1999. Journal of Antimicrobial Chemotherapy. 46(1). 125–128. 18 indexed citations
7.
Woodford, Neil & A. P. Johnson. (1994). Glycopeptide resistance in gram-positive bacteria: from black and white to shades of grey. Journal of Medical Microbiology. 40(6). 375–378. 11 indexed citations
8.
Sanyal, Debasish, et al.. (1993). In-vitro characteristics of glycopeptide resistant strains of Staphylococcus epidermidis isolated from patients on CAPD. Journal of Antimicrobial Chemotherapy. 32(2). 267–278. 31 indexed citations
9.
Tsakris, Athanasios, A. Vatopoulos, A. P. Johnson, et al.. (1992). Prevalence of a plasmid-mediated type II dihydrofolate reductase gene among trimethoprim-resistant urinary pathogens in Greek hospitals. Journal of Antimicrobial Chemotherapy. 29(4). 405–413. 7 indexed citations
10.
Johnson, A. P., et al.. (1984). Adherence of Staphylococcus aureus to Rabbit Corneal Epithelial Cells. Archives of Ophthalmology. 102(8). 1229–1231. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026